Product Information
PHENTERMINE 37.5 MG TABLET is a generic product labeled by Elite Laboratories, Inc., priced at $0.0708 per EA under NDC 64850081010. Its NADAC has been published 155 times since Jul 12, 2023.
Strength
37.5 mg/1
Manufacturer
Elite Laboratories, Inc.NDC
64850081010
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
PHENTERMINE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA040190On Market Since
5/1/2014
Pharmacological Classes
Price Statistics
The NADAC for PHENTERMINE 37.5 MG TABLET has been published 155 times since Jul 12, 2023, and over the history we have for it it has declined 21.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0708 per EA |
|---|---|
| All-time high | $0.1040 (Mar 13, 2024) |
| All-time low | $0.0494 (Nov 20, 2024) |
| 52-week high | $0.0777 |
| 52-week low | $0.0670 |
| Median price | $0.0736 |
| Average price | $0.0739 |
| Largest weekly change | +51.9% (Jun 19, 2024) |
| Weeks tracked | 155 |
| Tracking since | Jul 12, 2023 |
Generic Alternatives
The matcher finds 7 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 7 manufacturers (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 2% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of PHENTERMINE 37.5 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for PHENTERMINE 37.5 MG TABLET, manufactured by Elite Laboratories, Inc., is $0.0708 per EA (NDC 64850081010), effective Jun 24, 2026.
How has the price of PHENTERMINE 37.5 MG TABLET changed over time?
Over the history we have for it, the NADAC for PHENTERMINE 37.5 MG TABLET has declined 21.8%. It has been tracked across 155 weekly CMS publications since Jul 12, 2023.
What are the highest and lowest recorded NADAC prices for PHENTERMINE 37.5 MG TABLET?
Since Jul 12, 2023, the NADAC for PHENTERMINE 37.5 MG TABLET has ranged from a low of $0.0494 (Nov 20, 2024) to a high of $0.1040 (Mar 13, 2024), with a median of $0.0736 per EA.
Are there cheaper alternatives to PHENTERMINE 37.5 MG TABLET?
Yes. 7 NADAC-published products share the same active ingredient, strength, and dosage form. The lowest-priced option, PHENTERMINE 37.5 MG TABLET, is $0.0697 per EA — about 2% below PHENTERMINE 37.5 MG TABLET.
Who manufactures PHENTERMINE 37.5 MG TABLET?
PHENTERMINE 37.5 MG TABLET (NDC 64850081010) is labeled by Elite Laboratories, Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification